Favorable α‐fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation

Abstract

A favorable alpha-fetoprotein decrease has better predictive power for disease-free survival than for an unfavorable alpha-fetoprotein decrease. HCC patients after RFA with an unfavorable alpha-fetoprotein decrease should be considered to have undergone incomplete treatment, despite the complete response by standard image modality post-RFA.